Dopamine D3 receptor — Drug Target

All drugs that target Dopamine D3 receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Dopamine D3 receptor antagonist

Phase 2 pipeline (1)

• BL 1020 High Dose · BioLineRx, Ltd. · Dopamine D3 receptor antagonist · Psychiatry
  BL 1020 is a dopamine D3 receptor antagonist that modulates dopaminergic signaling in the brain.